细胞分裂周期相关蛋白7通过增强细胞增殖和干性促进人乳腺癌进程

杨得草 刘程 马集 王梦远 战军 张宏权

解剖学报 ›› 2020, Vol. 51 ›› Issue (6) : 888-896.

PDF(10017 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(10017 KB)
解剖学报 ›› 2020, Vol. 51 ›› Issue (6) : 888-896. DOI: 10.16098/j.issn.0529-1356.2020.06.013
肿瘤生物学

细胞分裂周期相关蛋白7通过增强细胞增殖和干性促进人乳腺癌进程

  • 杨得草 刘程 马集 王梦远 战军* 张宏权*
作者信息 +

Cell division cycle associated 7 promoteing breast cancer progression by enhancing proliferation and stemness of breast cancer cell

  • YANG De-cao LIU Cheng  MA Ji  WANG Meng-yuan  ZHAN Jun*  ZHANG Hong-quan*
Author information +
文章历史 +

摘要

目的  探讨细胞分裂周期相关蛋白7(CDCA7)在人类乳腺癌中的相关功能及潜在的作用机制。  方法 通过癌症和肿瘤基因图谱(TCGA)数据库分析检索出不同乳腺癌亚型差异表达基因,找到在基底型乳腺癌中高表达基因,在这些基因中找到CDCA7,通过临床患者的相关标本做免疫组织化学分析,确定其研究意义,进而建立CDCA7稳转细胞系,通过集落形成实验、成球实验及流式细胞术分析研究其在乳腺癌中的功能,最后通过Real-time PCR及Western blotting实验分析其在乳腺癌中的分子机制。 结果  数据库和免疫组织化学结果均显示,CDCA7在基底型乳腺癌细胞中表达高于其他亚型,高表达的CDCA7预示乳腺癌患者不良预后。在luminal细胞系中稳定地过表达CDCA7后,细胞表现出更强的增殖能力,进入分裂期的细胞明显增多,而凋亡细胞显著减少。同时流式细胞术分析表明,过表达CDCA7的细胞表现出了干细胞标记(CD133, 乙醛脱氢酶)上调。Real-time PCR 和Western blotting结果提示,CDCA7能够上调β-连环蛋白(β-catenin)表达,以此影响Wnt信号通路,并影响细胞增殖和干性。  结论  CDCA7作为一个促瘤基因,能够通过依赖β-catenin以及Wnt信号通路的方式来诱导luminal乳腺癌细胞向basal-like亚型转化的能力。

Abstract

Objective  To investigate the role of cell division cycle associated 7 (CDCA7) in breast cancer and the potential mechanisms among the progressioned.   Methods  By data analysis in data base to retrieve the differential expression gene and find out highly expressed genes in basal-like breast cancer cells. Among these genes we selected the attractive CDCA7 as the target of investigation. Through specimen immunohistochemistry analysis of clinical patients to confirm the significance of the research. Then we constructed CDCA7 stable expression cell lines to preform a series of experiments including colony formation assays, tumorsphere formation assays, flow cytometry, Western blotting and Real-time PCR to clear the role of CDCA7 in breast cancer.   Results  Data base analysis and histochemistry showed CDCA7 was highly expressed in basal-like breast cancer cells and high expression of CDCA7 predicts poor prognosis. Overexpressing CDCA7 in luminal cell lines, the cell lines showed stronger proliferative capacity, more mitotic cell and less apoptotic cell. Meanwhile, the markers of stem cell, such as CD133 and acetaldehyde dehydrogenase(ALDH) showed being upregulated. The Real-time PCR and Western blotting analysis showed that CDCA7 increased the expression of β-catenin, through which CDCA7 effected the Wnt pathway so as to influence cell proliferation and stemness.   Conclusion  CDCA7 as a oncogenic gene induces luminal cell to transform to basal-like subtype by depending on β-catenin and Wnt pathway.

关键词

细胞分裂周期相关蛋白7 / Basal-like/luminal乳腺癌 / 干细胞 / β-连环蛋白 / 流式细胞术 /

Key words

Cell division cycle associated 7 / Basal-like/luminal breast cancer / Stem cell / β-catenin / Flow cytometry / Human

引用本文

导出引用
杨得草 刘程 马集 王梦远 战军 张宏权. 细胞分裂周期相关蛋白7通过增强细胞增殖和干性促进人乳腺癌进程[J]. 解剖学报. 2020, 51(6): 888-896 https://doi.org/10.16098/j.issn.0529-1356.2020.06.013
YANG De-cao LIU Cheng MA Ji WANG Meng-yuan ZHAN Jun ZHANG Hong-quan. Cell division cycle associated 7 promoteing breast cancer progression by enhancing proliferation and stemness of breast cancer cell[J]. Acta Anatomica Sinica. 2020, 51(6): 888-896 https://doi.org/10.16098/j.issn.0529-1356.2020.06.013
中图分类号: Q291    

参考文献

[1] Ferlay J, Soerjomataram I, Dikshit R, et al.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer, 2015, 136(5):E359-386.
[2] Bianchini G, Balko JM, Mayer IA, et al.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J]. Nat Rev Clin Oncol, 2016, 13(11):674-690.
[3] Parker JS, Mullins M, Cheang MC, et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes [J]. J Clin Oncol, 2009, 27(8):1160-1167.
[4] Prat A, Parker JS, Karginova O, et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer [J]. Breast Cancer Res, 2010, 12(5):R68.
[5] Ricardo S, Vieira AF, Gerhard R, et al.  Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype [J]. J Clin Pathol, 2011, 64(11):937-946.
[6] Holliday DL, and Speirs V, Choosing the right cell line for breast cancer research [J]. Breast Cancer Res, 2011, 13(4):215.
[7] Andersen JN, Sathyanarayanan S, Di Bacco A, et al.  Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors [J]. Sci Transl Med, 2010, 2(43):43ra55.
[8] Dittmer J. Breast cancer stem cells: Features, key drivers and treatment options [J]. Semin Cancer Biol, 2018, 53:59-74.
[9] Maugeri-Sacca M, De Maria R. Hippo pathway and breast cancer stem cells [J]. Crit Rev Oncol Hematol, 2016, 99:115-122.
[10] Whitfield ML, Sherlock G, Saldanha AJ, et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors [J]. Mol Biol Cell, 2002, 13(6):1977-2000.
[11] Prescott JE, Osthus RC, Lee LA, et al.  A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation [J]. J Biol Chem, 2001, 276(51):48276-48284.
[12] Goto Y, Hayashi R, Muramatsu T, et al.  JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity [J]. Biochim Biophys Acta, 2006, 1759(12):60-68.
[13] Guiu J, Bergen DJ, De Pater E, et al.  Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence [J]. J Exp Med, 2014, 211(12):2411-2423.
[14] Ye L, Li F, Song Y, et al.  Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer [J]. Int J Cancer, 2018, 143(10):2602-2613.
[15] Nusse R, Clevers H. Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities [J]. Cell, 2017, 169(6):985-999.
[16] Van Camp JK, Beckers S, Zegers D, et al.  Wnt signaling and the control of human stem cell fate [J]. Stem Cell Rev Rep, 2014, 10(2):207-229.
[17] Alexander CM. The wnt signaling landscape of mammary stem cells and breast tumors [J]. Prog Mol Biol Transl Sci, 2018, 153:271-298.
[18] Yu QC, Verheyen EM, Zeng YA. Mammary development and breast cancer: a wnt perspective [J]. Cancers (Basel), 2016, 8(7):65.
[19] Mohammed MK, Shao C, Wang J, et al.  Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance [J]. Genes Dis, 2016, 3(1):11-40.
[20] Domenici G, Aurrekoetxea-Rodriguez I, Simoes BM, et al.  A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells [J]. Oncogene, 2019, 38(17):3151-3169.
[21] Feng W, Liu S, Zhu R, et al.  SOX10 induced Nestin expression regulates cancer stem cell properties of TNBC cells [J]. Biochem Biophys Res Commun, 2017, 485(2):522-528.
[22] Ihemelandu CU, Naab TJ, Mezghebe HM, et al.  Basal cell-like (triple-negative) breast cancer, a predictor of distant metastasis in African American women [J]. Am J Surg, 2008, 195(2):153-158.

基金

国家自然科学基金;科技部专项基金;北京市自然科学基金

PDF(10017 KB)

Accesses

Citation

Detail

段落导航
相关文章

/